XORTX Therapeutics Inc (NASDAQ:XRTX) has a beta value of 0.49 and has seen 0.24 million shares traded in the last trading session. The company, currently valued at $3.13M, closed the last trade at $0.90 per share which meant it lost -$0.06 on the day or -6.25% during that session. The XRTX stock price is -677.78% off its 52-week high price of $7.00 and 5.56% above the 52-week low of $0.85. If we look at the company’s 10-day average daily trading volume, we find that it stood at 49720.0 shares traded. The 3-month trading volume is 106.31K shares.

XORTX Therapeutics Inc (NASDAQ:XRTX) trade information

Sporting -6.25% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the XRTX stock price touched $0.90 or saw a rise of 7.22%. Year-to-date, XORTX Therapeutics Inc shares have moved -20.33%, while the 5-day performance has seen it change 1.26%. Over the past 30 days, the shares of XORTX Therapeutics Inc (NASDAQ:XRTX) have changed -18.18%. Short interest in the company has seen 24486.0 shares shorted with days to cover at 0.09.

XORTX Therapeutics Inc (XRTX) estimates and forecasts

The company’s shares have lost -38.57% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.21% over the past 5 years.

XRTX Dividends

XORTX Therapeutics Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

XORTX Therapeutics Inc (NASDAQ:XRTX)’s Major holders

Insiders own 3.04% of the company shares, while shares held by institutions stand at 7.58% with a share float percentage of 7.81%. Investors are also buoyed by the number of investors in a company, with XORTX Therapeutics Inc having a total of 6.0 institutions that hold shares in the company.